These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 18547346)

  • 1. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
    Nonaka D; Chiriboga L; Rubin BP
    J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
    Jokinen CH; Dadras SS; Goldblum JR; van de Rijn M; West RB; Rubin BP
    Am J Clin Pathol; 2008 Jun; 129(6):886-93. PubMed ID: 18480004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
    Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
    Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
    Fullen DR; Garrisi AJ; Sanders D; Thomas D
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():28-34. PubMed ID: 18201235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
    Lazova R; Tantcheva-Poor I; Sigal AC
    J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actin expression in neural crest cell-derived tumors including schwannomas, malignant peripheral nerve sheath tumors, neurofibromas and melanocytic tumors.
    Dundr P; Povýsil C; Tvrdík D
    Pathol Int; 2009 Feb; 59(2):86-90. PubMed ID: 19154261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox10: a pan-schwannian and melanocytic marker.
    Nonaka D; Chiriboga L; Rubin BP
    Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical evaluation of canine peripheral nerve sheath tumors and other soft tissue sarcomas.
    Chijiwa K; Uchida K; Tateyama S
    Vet Pathol; 2004 Jul; 41(4):307-18. PubMed ID: 15232130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feline cutaneous nerve sheath tumours: histological features and immunohistochemical evaluations.
    Mandara MT; Fabriani E; Pavone S; Pumarola M
    Res Vet Sci; 2013 Oct; 95(2):548-55. PubMed ID: 23659741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
    Nabeshima K; Iwasaki H; Nishio J; Koga K; Shishime M; Kikuchi M
    Anticancer Res; 2006; 26(2B):1359-67. PubMed ID: 16619545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of tissue microarray technology in malignant peripheral nerve sheath tumours.
    Cunha KS; Caruso AC; Gonçalves AS; Bernardo VG; Pires AR; da Fonseca EC; de Faria PA; da Silva LE; Geller M; de Moura-Neto RS; Lopes VS
    J Clin Pathol; 2009 Jul; 62(7):629-33. PubMed ID: 19318344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
    Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
    Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nestin expression as a new marker in malignant peripheral nerve sheath tumors.
    Shimada S; Tsuzuki T; Kuroda M; Nagasaka T; Hara K; Takahashi E; Hayakawa S; Ono K; Maeda N; Mori N; Illei PB
    Pathol Int; 2007 Feb; 57(2):60-7. PubMed ID: 17300669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of GLUT-1 in oral peripheral nerve sheath tumors.
    Salla JT; Johann AC; Lana AM; do Carmo MA; Nunes FD; Mesquita RA
    Oral Dis; 2008 Sep; 14(6):510-3. PubMed ID: 18826382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoprofiles in malignant peripheral nerve sheath tumor: three case reports and literature review.
    Hu SW; Lin WC; Tsai HJ; Chien SH; Tsai KB
    Kaohsiung J Med Sci; 2006 Mar; 22(3):135-42. PubMed ID: 16602278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial malignant peripheral nerve sheath tumor: a rare and challenging diagnosis.
    Allison KH; Patel RM; Goldblum JR; Rubin BP
    Am J Clin Pathol; 2005 Nov; 124(5):685-92. PubMed ID: 16203275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of IRS2 in the progression from neurofibroma to malignant peripheral nerve sheath tumor.
    Shaw CM; Grobmyer SR; Ucar DA; Cance WG; Reith JD; Hochwald SN
    Anticancer Res; 2012 Feb; 32(2):439-43. PubMed ID: 22287730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.